Stockreport

HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration

HOOKIPA Pharma Inc.  (HOOK) 
Last hookipa pharma inc. earnings: 3/19 07:00 am Check Earnings Report
PDF HOOKIPA announces alignment with FDA on pivotal trial design and protocol for HB-200 in combination with pembrolizumabHB-200 program receives Priority Medicines (PRIME) [Read more]